Maropitant
Maropitant citrate
由 VetSheet 獸醫團隊審訂更新於 2026年4月13日本內容以實證獸醫文獻為本
2 mg/kgPO· q24h· Up to 14 days
— 🐕
劑量為合格獸醫專業人員的臨床參考。請務必對照最新仿單及個別病患確認。
各物種劑量
🌎 NA — North America🌍 EU — Europe
狗
| 適應症 | 劑量 | 途徑 | 頻次 | 療程 | 地區 |
|---|---|---|---|---|---|
| Treatment and prevention of vomiting (except motion sickness); prevention of chemotherapy-induced nausea | 2 mg/kg | PO | q24h | Up to 14 days | 🌍 EU |
| Prevention of vomiting induced by motion sickness | 8 mg/kg | PO | q24h | Maximum 2 consecutive days | 🌍 EU |
| Treatment and prevention of vomiting; chemotherapy-induced nausea (injectable) | 1 mg/kg (1 ml/10 kg) | SC or IV | q24h | Up to 5 consecutive days | 🌍 EU |
- Treatment and prevention of vomiting (except motion sickness); prevention of chemotherapy-induced nausea: Dogs 8 weeks of age or older. Give more than 1 hour in advance to prevent vomiting; effect lasts approx. 24 h. A correct dose cannot be accurately achieved in dogs under 3 kg.
- Prevention of vomiting induced by motion sickness: Dogs 16 weeks of age or older. Give at least 1 hour before the journey; anti-emetic effect persists at least 12 h.
- Treatment and prevention of vomiting; chemotherapy-induced nausea (injectable): IV administration must be given as a single bolus without mixing with other fluids.
貓
| 適應症 | 劑量 | 途徑 | 頻次 | 療程 | 地區 |
|---|---|---|---|---|---|
| Treatment and prevention of vomiting (injectable) | 1 mg/kg (1 ml/10 kg) | SC or IV | q24h | Up to 5 consecutive days | 🌍 EU |
- Treatment and prevention of vomiting (injectable): IV administration must be given as a single bolus without mixing with other fluids. The injectable is the only Cerenia presentation authorised in cats — the tablets are dogs only.
劑量為合格獸醫專業人員的臨床參考。請務必對照最新仿單及個別病患確認。
概覽
A neurokinin-1 (NK1) receptor antagonist that blocks the pharmacological action of substance P in the central nervous system, widely used in veterinary medicine to prevent and treat vomiting.
安全性與警告
不良反應
- Pain at injection site
- Lethargy
- Anorexia
- Diarrhea
- Hypersalivation
VetSheet 藥物參考供合格獸醫專業人員作臨床決策輔助之用,不能取代專業判斷或廠商最新仿單。
